Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 83

Sort by

Sort Order Select

Journal Articles

What's new in the prevention and treatment of cancer-associated thrombosis?

Miriam Kimpton, Marc Carrier

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 158–166.

https://doi.org/10.1182/hematology.2019000023

Published: 2019

Journal Articles

Update from the laboratory: mechanistic studies of pathways of cancer-associated venous thrombosis using mouse models

Yohei Hisada, Nigel Mackman

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 182–186.

https://doi.org/10.1182/hematology.2019000025

Published: 2019

Journal Articles

Is there a role for low-dose DOACs as prophylaxis?

Alexander T. Cohen, Beverley J. Hunt

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 187–193.

https://doi.org/10.1182/hematology.2019000026

Published: 2019

Journal Articles

Update from the clinic: what’s new in the diagnosis of cancer-associated thrombosis?

Erica A. Peterson, Agnes Y. Y. Lee

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 167–174.

https://doi.org/10.1182/hematology.2019000024

Published: 2019

Journal Articles

Case-based discussion on the implications of exogenous estrogens in hemostasis and thrombosis: the obstetrician’s view

Andra H. James

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 148–151.

https://doi.org/10.1182/hematology.2019000071

Published: 2019

Journal Articles

Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy

Hanny Al-Samkari, Jean M. Connors

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 71–79.

https://doi.org/10.1182/hematology.2019000369

Published: 2019

Journal Articles

Who should get long-term anticoagulant therapy for venous thromboembolism and with what?

Marc Alan Rodger, Gregoire Le Gal

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 426–431.

https://doi.org/10.1182/asheducation-2018.1.426

Published: 2018

Journal Articles

Breadth of complications of long-term oral anticoagulant care

Walter Ageno, Marco Donadini

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 432–438.

https://doi.org/10.1182/asheducation-2018.1.432

Published: 2018

Journal Articles

The current state of sickle cell trait: implications for reproductive and genetic counseling

Lydia H. Pecker, Rakhi P. Naik

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 474–481.

https://doi.org/10.1182/asheducation-2018.1.474

Published: 2018

Journal Articles

Anticoagulating patients with high-risk acquired thrombophilias

Leslie Skeith

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 439–449.

https://doi.org/10.1182/asheducation-2018.1.439

Published: 2018

Journal Articles

Management of thrombosis in children and neonates: practical use of anticoagulants in children

Paul Monagle, Fiona Newall

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 399–404.

https://doi.org/10.1182/asheducation-2018.1.399

Published: 2018

Journal Articles

Direct oral anticoagulants: now also for prevention and treatment of cancer-associated venous thromboembolism?

Ingrid Pabinger, Julia Riedl

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 136–143.

https://doi.org/10.1182/asheducation-2017.1.136

Published: 2017

Journal Articles

Should we diagnose and treat distal deep vein thrombosis?

Helia Robert-Ebadi, Marc Righini

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 231–236.

https://doi.org/10.1182/asheducation-2017.1.231

Published: 2017

Journal Articles

Preventing venous thromboembolism during pregnancy and postpartum: crossing the threshold

Leslie Skeith

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 160–167.

https://doi.org/10.1182/asheducation-2017.1.160

Published: 2017

Journal Articles

Controversies in venous thromboembolism: to treat or not to treat superficial vein thrombosis

Jan Beyer-Westendorf

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 223–230.

https://doi.org/10.1182/asheducation-2017.1.223

Published: 2017

Journal Articles

Incidental venous thromboembolism: is anticoagulation indicated?

Marcello Di Nisio, Marc Carrier

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 121–127.

https://doi.org/10.1182/asheducation-2017.1.121

Published: 2017

Journal Articles

When can we stop anticoagulation in patients with cancer-associated thrombosis?

Agnes Y. Y. Lee

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 128–135.

https://doi.org/10.1182/asheducation-2017.1.128

Published: 2017

Journal Articles

Thrombosis in the setting of cancer

Michael B. Streiff

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 196–205.

https://doi.org/10.1182/asheducation-2016.1.196

Published: 2016

Journal Articles

Diagnosis of suspected venous thromboembolism

Clive Kearon

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 397–403.

https://doi.org/10.1182/asheducation-2016.1.397

Published: 2016

Journal Articles

Prevention of thrombosis in antiphospholipid syndrome

Wendy Lim

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 707–713.

https://doi.org/10.1182/asheducation-2016.1.707

Published: 2016

NARROW

What's new in the prevention and treatment of cancer-associated thrombosis?

Update from the laboratory: mechanistic studies of pathways of cancer-associated venous thrombosis using mouse models

Is there a role for low-dose DOACs as prophylaxis?

Update from the clinic: what’s new in the diagnosis of cancer-associated thrombosis?

Case-based discussion on the implications of exogenous estrogens in hemostasis and thrombosis: the obstetrician’s view

Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy

Who should get long-term anticoagulant therapy for venous thromboembolism and with what?

Breadth of complications of long-term oral anticoagulant care

The current state of sickle cell trait: implications for reproductive and genetic counseling

Anticoagulating patients with high-risk acquired thrombophilias

Management of thrombosis in children and neonates: practical use of anticoagulants in children

Direct oral anticoagulants: now also for prevention and treatment of cancer-associated venous thromboembolism?

Should we diagnose and treat distal deep vein thrombosis?

Preventing venous thromboembolism during pregnancy and postpartum: crossing the threshold

Controversies in venous thromboembolism: to treat or not to treat superficial vein thrombosis

Incidental venous thromboembolism: is anticoagulation indicated?

When can we stop anticoagulation in patients with cancer-associated thrombosis?

Thrombosis in the setting of cancer

Diagnosis of suspected venous thromboembolism

Prevention of thrombosis in antiphospholipid syndrome

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only